Loading...

PE/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PECy7_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
  • 30-F11_PECy7_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103113 25 µg 70€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103114 100 µg 152€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Rodriguez de la Fuente L, et al. 2021. STAR Protoc. 2:100841. PubMed
  2. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  3. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  4. Yang AC, et al. 2020. Nature. 583:425. PubMed
  5. Chen G, et al. 2021. J Mol Cell Cardiol. 159:62. PubMed
  6. Kfoury YS, et al. 2021. Cell Stem Cell. 28:2090. PubMed
  7. He D, et al. 2022. Immunity. 55:159. PubMed
  8. Tapanes S, et al. 2022. Glia. 70:1133. PubMed
  9. Kenney DJ, et al. 2022. Cell Rep. 39:110714. PubMed
  10. Jeong GU, et al. 2022. Microbiol Spectr. 10:e0109122. PubMed
  11. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  12. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  13. Steudler J, et al. 2022. Glia. 70:2045. PubMed
  14. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  15. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  16. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  17. McNamara NB, et al. 2023. Nature. 613:120. PubMed
  18. Moiseeva V, et al. 2023. Nature. 613:169. PubMed
  19. An X, et al. 2023. Am J Reprod Immunol. 89:e13676. PubMed
  20. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  21. Taniguchi S, et al. 2023. Nat Commun. 14:143. PubMed
  22. Murakata Y, et al. 2023. Front Cardiovasc Med. 9:1075358. PubMed
  23. Hattori Y, et al. 2023. Cell Rep. 42:112092. PubMed
  24. Ismailova A, et al. 2023. Front Immunol. 14:1123344. PubMed
  25. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  26. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  27. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  28. Narvaez del Pilar O, et al. 2022. Development. 149:. PubMed
  29. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  30. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  31. Khare A, et al. 2016. Cell Rep. 15: 1700-1714. PubMed
  32. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  33. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  34. Garber C, et al. 2019. Nat Neurosci. 1.802777778. PubMed
  35. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  36. Wu JH, et al. 2020. EMBO Mol Med. 12:e10154. PubMed
  37. Hernandez BJ, et al. 2022. Am J Respir Cell Mol Biol. 67:389. PubMed
  38. Meyer T, et al. 2022. Proc Natl Acad Sci U S A. 119:e2211310119. PubMed
  39. Hong X, et al. 2022. Cell Stem Cell. 29:1298. PubMed
  40. Cronin SJF, et al. 2022. Sci Transl Med. 14:eabj1531. PubMed
  41. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  42. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  43. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  44. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  45. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  46. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  47. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  48. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  49. Bobadilla Muñoz M, et al. 2023. Front Cell Dev Biol. 11:1128534. PubMed
  50. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  51. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  52. Kim SS, et al. 2022. Cancers (Basel). 14:. PubMed
  53. García-Prat L, et al. 2020. Nat Cell Biol. 22:1307. PubMed
  54. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  55. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  56. Helms EJ, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  57. Huck NA, et al. 2021. J Neurosci. 41:4349. PubMed
  58. Wu Q, et al. 2021. Cancer Commun (Lond). Online ahead of prin. PubMed
  59. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  60. Yagishita Y, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  61. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  62. Wagner G, et al. 2017. Sci Rep. 7:40881. PubMed
  63. Weeden C, et al. 2017. PLoS Biol. 10.1371/journal.pbio.2000731. PubMed
  64. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
  65. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  66. Smith NR, et al. 2017. Cell Mol Gastroenterol Hepatol. 0.395138889. PubMed
  67. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  68. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  69. Chang T, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006485. PubMed
  70. Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed
  71. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  72. Manivasagam S, et al. 2022. J Immunol. 208:1341. PubMed
  73. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  74. Vila Ellis L, et al. 2020. Dev Cell. 617:52. PubMed
  75. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  76. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  77. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  78. Mansouri N, et al. 2019. JCI Insight. 4:e128060. PubMed
  79. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  80. White MPJ, et al. 2020. Front Immunol. 11:1830. PubMed
  81. Saito S, et al. 2020. Nutrients. 12:. PubMed
  82. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  83. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  84. Little DR, et al. 2021. Nat Commun. 12:2509. PubMed
  85. Bhopale VM, et al. 2021. J Appl Physiol (1985). 130:1604. PubMed
  86. Zheng L, et al. 2022. J Neuroinflammation. 19:128. PubMed
  87. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  88. Britschgi A, et al. 2017. Nature. 541:541-545. PubMed
  89. Valds-Mora F, et al. 2021. Cell Reports. 35(2):108945. PubMed
  90. DellOrso S, et al. 2021. STAR Protocols. 2(2):100451. PubMed
  91. Wang B, et al. 2017. EBioMedicine. 10.1016/j.ebiom.2017.03.041. PubMed
  92. Kaczmarek–Hájek K, et al. 2018. Elife. 7:e36217. PubMed
  93. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  94. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  95. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  96. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  97. Campanario S, et al. 2021. Front Cell Dev Biol. 8:620409. PubMed
  98. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  99. Jiang YH, et al. 2020. J Mol Cell Cardiol. 138:115. PubMed
  100. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  101. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  102. Garber C, et al. 2018. Nat Immunol. 19:151. PubMed
  103. Mizuochi C, et al. 2012. PLoS One. 7:e35763. PubMed
  104. Gigliotti J, et al. 2013. J Am Soc Nephrol. 24:1451. PubMed
  105. Wang B,et al. 2017. Cell Discov.. 10.1038/celldisc.2017.36. PubMed
  106. Solanas G, et al. 2017. Cell. 170:678. PubMed
  107. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  108. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  109. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  110. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  111. Fix DK, et al. 2021. Aging Cell. 20:e13448. PubMed
  112. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  113. Zhu L, et al. 2021. Stem Cell Res Ther. 12:408. PubMed
  114. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  115. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  116. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  117. McGowan SE, et al. 2018. Am J Physiol Lung Cell Mol Physiol. 315:L102. PubMed
  118. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  119. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  120. Huang CH, et al. 2020. Adv Ther (Weinh). 3:. PubMed
  121. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  122. Okamura T, et al. 2021. Front Immunol. 12:669629. PubMed
  123. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  124. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  125. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  126. Allen S, et al. 2011. J Virol. 85:11448. PubMed
  127. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  128. Furuya Y, et al. 2015. PLoS Pathog. 11: 1005180. PubMed
  129. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  130. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  131. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  132. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  133. Onder L et al. 2017. Immunity. 47(1):80-92 . PubMed
  134. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  135. Kimbrough D, et al. 2018. J Mol Cell Cardiol. 119:51. PubMed
  136. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  137. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  138. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  139. Ellegast JM, et al. 2022. Cancer Discov. 12:1760. PubMed
  140. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  141. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  142. Manco R, et al. 2021. Nat Commun. 12:3074. PubMed
  143. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  144. Berg AL, et al. 2022. Cancers (Basel). 14:. PubMed
  145. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  146. McCoy S 2015. Am J Physiol Lung Cell Mol Physiol. 309: L463-L474. PubMed
  147. Yen Y, et al. 2008. J Virol. 82:12312. PubMed
  148. Uribesalgo I, et al. 2019. EMBO Mol Med. 11:e9266. PubMed
  149. Son NH, et al. 2018. J Clin Invest. 128:4329. PubMed
  150. Sela Y, et al. 2021. Elife. 10: . PubMed
  151. Ishii H, et al. 2012. Cell Death Dis. 9;3:e363. PubMed
  152. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  153. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  154. Kellish P, et al. 2019. J Clin Invest. 130:2279. PubMed
  155. Magri G et al. 2017. Immunity. 47(1):118-134 . PubMed
  156. Pascual G, et al. 2021. Nature. 599:485. PubMed
  157. Kolodziejczyk AA, et al. 2020. Nat Med. 26:1899. PubMed
  158. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  159. Chu X, et al. 2021. Front Cell Dev Biol. 9:671841. PubMed
  160. Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed
  161. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  162. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  163. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  164. Jin L, et al. 2022. J Immunol Res. 2022:7222638. PubMed
  165. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  166. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  167. Wu X, et al. 2016. Sci Rep. 6:18685. PubMed
  168. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  169. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  170. van Gastel N, et al. 2020. Cell Metabolism. 32(3):391-403.e6. PubMed
  171. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  172. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  173. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  174. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  175. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  176. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  177. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  178. Li J, et al. 2020. Development. :. PubMed
  179. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  180. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  181. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  182. Mohammadpour H, et al. 2021. Cell Rep. 37:109883. PubMed
  183. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  184. Sung PS, et al. 2022. JCI Insight. :. PubMed
  185. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  186. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  187. Wang W, et al. 2021. STAR Protocols. 2(3):100756. PubMed
  188. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  189. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  190. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  191. Nian Z, et al. 2021. Clin Cancer Res. 27:6026. PubMed
  192. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  193. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
  194. Ognjenovic NB, et al. 2020. Dev Cell. 55:544. PubMed
  195. Gu H, et al. 2021. Elife. 10:. PubMed
  196. Hendee K, et al. 2021. Aging (Albany NY). 13:7781. PubMed
  197. Issah Y, et al. 2021. Elife. 10:. PubMed
  198. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  199. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  200. Smith NR, et al. 2018. Cell Mol Gastroenterol Hepatol. 6:79. PubMed
  201. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  202. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  203. Fan X, et al. 2020. Acta Physiol (Oxf). 230:e13475. PubMed
  204. Fang Y, et al. 2022. Development. 149:. PubMed
  205. Boyce M, et al. 2022. Cells. 11:. PubMed
  206. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  207. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  208. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  209. Béchade C, et al. 2020. Glia. . PubMed
  210. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  211. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  212. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  213. Li Q, et al. 2022. J Biol Chem. :101753. PubMed
  214. Dong H, et al. 2022. Nat Metab. 4:90. PubMed
  215. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  216. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  217. Sheng J, et al. 2021. eLife. 10:00. PubMed
  218. Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed
  219. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  220. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  221. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  222. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  223. Hussein M, et al. 2015. PLoS One. 10: 0135218. PubMed
  224. Gigliotti J, et al. 2015. J Am Soc Nephrol. 26: 2470 - 2481. PubMed
  225. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  226. Gerner-Mauro KN, et al. 2020. Proc Natl Acad Sci U S A. 117:12182. PubMed
  227. Kimmel JC, et al. 2021. Cell Reports. 35(4):109046. PubMed
  228. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  229. Ghosh S, et al. 2019. Commun Biol. 0.325. PubMed
  230. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  231. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  232. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  233. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  234. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
  235. Wu H, et al. 2020. Cell. 180(1):107-121.e17.. PubMed
  236. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
RRID
AB_312978 (BioLegend Cat. No. 103113)
AB_312979 (BioLegend Cat. No. 103114)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD45
Specificity Alt (DOES NOT SHOW ON TDS):
CD45
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account